Libtayo Dosage

Generic name: cemiplimab-rwlc
Drug class: Anti-PD-1 monoclonal antibodies

Medically reviewed by  A Ras MD.

Recommended Adult Dosing

Dosage forms:  INJ

Cutaneous squamous cell CA, locally advanced or metastatic

[350 mg IV q3wk]

Info: for pts not eligible for curative surgery or XRT

Basal cell CA, locally advanced or metastatic

[350 mg IV q3wk]

Info: for pts who have received a hedgehog pathway inhibitor or for whom a hedgehog pathway inhibitor is not appropriate

Locally advanced or metastatic non-small cell lung CA, first-line tx

[350 mg IV q3wk]

Info: for pts w/ high PD-L1-expressing tumor w/ no EGFR, ALK, or ROS1 genomic tumor aberrations not eligible for curative surgery or XRT

Renal dosing

CrCl >21: no adjustment; CrCl <21: not defined

HD/PD: not defined

Hepatic dosing

bilirubin 1.1-3x ULN: no adjustment; bilirubin >3x ULN: not defined

SRC: NLM .